tert-Butyl 3-cyano-3-acetamidopyrrolidine-1-carboxylate

Catalog No. :
ACAHIF025
CAS No. :
1803582-78-6
Molecular Formula :
C12H19N3O3
Molecular Weight :
253.30

IUPAC Name:tert-butyl 3-acetamido-3-cyanopyrrolidine-1-carboxylate

tert-Butyl 3-cyano-3-acetamidopyrrolidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$264.00Login to see priceInquiryInquiry
100mg95%$383.00Login to see priceInquiryInquiry
250mg95%$540.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-cyano-3-acetamidopyrrolidine-1-carboxylate
IUPAC Nametert-butyl 3-acetamido-3-cyanopyrrolidine-1-carboxylate
MDL No.MFCD28714553
Molecular FormulaC12H19N3O3
Molecular Weight253.30
SMILESO=C(N1CC(NC(C)=O)(C#N)CC1)OC(C)(C)C
InChI KeyIXLNDWHUHHMDEG-UHFFFAOYSA-N
Synonym1-Pyrrolidinecarboxylic acid, 3-(acetylamino)-3-cyano-, 1,1-dimethylethyl ester;tert-Butyl 3-cyano-3-acetamidopyrrolidine-1-carboxylate
CAS No.1803582-78-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACAHIF025 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  6. Then
  7. ACAHIF025 route product structure diagram
    ACAHIF0251803582-78-6
Inquiry

2. ACAHIF025 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBXQZ394 route compound structure diagram
    ACBXQZ394871115-54-7 In Stock
  4. Then
  5. ACAHIF025 route product structure diagram
    ACAHIF0251803582-78-6
Inquiry

Comments (0)